Dual neurokinin NK1/NK2 antagonists: N-[(R,R)-(E)-1-arylmethyl-3-(2-oxo-azepan-3-yl)carbamoyl]allyl-N-methyl-3,5-bis(trifluoromethyl)benzamides and 3-[N′-3,5-bis(trifluoromethyl)benzoyl-N-arylmethyl-N′-methylhydrazino]-N-[(R)-2-oxo-azepan-3-yl]propionamides-Reference-Cited by-同舟云学术

Dual neurokinin NK1/NK2 antagonists: N-[(R,R)-(E)-1-arylmethyl-3-(2-oxo-azepan-3-yl)carbamoyl]allyl-N-methyl-3,5-bis(trifluoromethyl)benzamides and 3-[N′-3,5-bis(trifluoromethyl)benzoyl-N-arylmethyl-N′-methylhydrazino]-N-[(R)-2-oxo-azepan-3-yl]propionamides

Published:2001-12 Issue:23 Volume:11 Page:3081-3084
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Gerspacher Marc,La Vecchia Luigi,Mah Robert,von Sprecher Andreas,Anderson Gary P.,Subramanian Natarajan,Hauser Kathleen,Bammerlin Heinrich,Kimmel Sabine,Pawelzik Viviane,Ryffel Karin,Ball Howard A.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference21 articles.

1. Section Review—Central & Peripheral Nervous Systems: Tachykinin Antagonists in Development

2. Neurokinin receptor antagonists

3. Neurokinin-receptor antagonists: pharmacological tools and therapeutic drugs

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging drug for diarrhea predominant irritable bowel syndrome;Expert Opinion on Emerging Drugs;2015-03-03

2. Pharmacophore Modeling, Virtual Screening, and in Vitro Testing Reveal Haloperidol, Eprazinone, and Fenbutrazate as Neurokinin Receptors Ligands;Journal of Chemical Information and Modeling;2014-06-12

3. Future treatment options for atopic dermatitis – Small molecules and beyond;Journal of Dermatological Science;2014-02

4. Randomised clinical trial: the clinical effects of a novel neurokinin receptor antagonist, DNK333, in women with diarrhoea-predominant irritable bowel syndrome;Alimentary Pharmacology & Therapeutics;2011-04-20

5. Neurokinin-1 receptor antagonists: a comprehensive patent survey;Expert Opinion on Therapeutic Patents;2010-06-10